From American Diabetes Association <[email protected]>
Subject Navigating risks with compounded medications
Date March 22, 2025 3:36 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Differences and risks between FDA-approved, compounded, and
counterfeit medications.

[link removed]

Compounded Medications: Navigating Risks in Diabetes and Obesity
Treatments

Check out this month's new Diabetes Day by Day podcast episode!
Listen as we delve into a crucial topic that affects many:
understanding the differences between Food and Drug Administration
(FDA)-approved, compounded, and counterfeit medications.

Special guests this month:

*  Dr. Susan Kuchera, Clinical Assistant Professor of Family
and Community Medicine at the Sidney Kimmel Medical College of
Thomas Jefferson University and Program Director of the Family
Medicine Residency at Jefferson Health Abington
* Lisa Kessler, MS, CCC-SLP, Infant-Toddler Home-Based Pediatric
Speech-Language Pathologist

Key takeaways:

* The difference between FDA-approved, compounded, and counterfeit
medications
* Risks and concerns of compounded medications
* How FDA-approved medications stack up against compounded ones
* What to consider before using compounded medications

Listen Now
[link removed]

Listen on Apple Music, Spotify, or wherever you get your
podcasts! 

Looking for meal planning tools? Check out ShopDiabetes.org for
placemats, portion plates, and more.
[link removed]

Facebook

[link removed]

Twitter

[link removed]

Instagram

[link removed]

Linkedin

[link removed]

YouTube

[link removed]

© American Diabetes Association. All rights reserved.

[email protected] | 1-800-342-2383

Learn more at diabetes.org
[link removed]

Forward to a Friend | Manage Your Communication | Unsubscribe
[link removed]

[link removed]
[link removed]
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a